PML and acute promyelocytic leukemia: Specifically, TRIB3 inhibits ubiquitylation and degradation of promyelocytic leukemia protein (PML) in acute promyelocytic leukemia progression by repressing proteasome recruitment and interaction with PML and by inhibiting the ubiquitin proteasome system activity [13].